Medgenics, Inc. (NYSE MKT: MDGN and AIM: MEDU, MEDG) (the Company), the developer of a novel technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue, announces that the Company will host an investment community conference call on Friday, November 8, 2013 beginning at 8:30 a.m.
Help employers find you! Check out all the jobs and post your resume.
